At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Yewdell, J. W.
	Articles by Bennink, J. R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Yewdell, J. W.
	Articles by Bennink, J. R.

Anton, L. C., Snyder, H. L., Bennink, J. R., Vinitsky, A., Orlowski, M., Porgador, A. and Yewdell, J. W (1998). Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J. Immunol 160, 4859-4868.[Abstract/Free Full Text]

Anton, L. C., Schubert, U., Bacik, I., Princiotta, M. F., Wearsch, P. A., Gibbs, J., Day, P. M., Realini, C., Rechsteiner, M. C., Bennink, J. R. and Yewdell, J. W (1999). Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol 146, 113-124.[Abstract/Free Full Text]

Benham, A. M., Gromme, M. and Neefjes, J (1998). Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J. Immunol 161, 83-89.[Abstract/Free Full Text]

Bogyo, M., Gaczynska, M. and Ploegh, H. L (1997). Proteasome inhibitors and antigen presentation. Biopolymers 43, 269-280.[Medline]

Cerundolo, V., Benham, A., Braud, V., Mukherjee, S., Gould, K., Macino, B., Neefjes, J. and Townsend, A (1997). The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol 27, 336-341.[Medline]

Elliott, T (1997). Transporter associated with antigen processing. Advan. Immunol 65, 47-109.[Medline]

Engelhard, V. H (1994). Structures of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol 12, 181-207.[Medline]

Esquivel, F., Yewdell, J. W. and Bennink, J. R (1992). RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med 175, 163-168.[Abstract/Free Full Text]

Falk, K., R\232tzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G (1991). Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.[Medline]

Garcia, K. C., Teyton, L. and Wilson, I. A (1999). Structural basis of T cell recognition. Annu. Rev. Immunol 17, 369-397.[Medline]

Glickman, M. H., Rubin, D. M., Fu, H., Larsen, C. N., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., Vierstra, R., Baumeister, W., Fried, V. and Finley, D (1999). Functional analysis of the proteasome regulatory particle. Mol. Biol. Rep 26, 21-28.[Medline]

Haas, A. L. and Bright, P. M (1985). The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. J. Biol. Chem 260, 12464-12473.[Abstract/Free Full Text]

Hendil, K. B (1988). The 19 S multicatalytic \324prosome' proteinase is a constitutive enzyme in HeLa cells. Biochem. Int 17, 471-477.[Medline]

Hershko, A. and Ciechanover, A (1998). The ubiquitin system. Annu. Rev. Biochem 67, 425-479.[Medline]

Lin, L., DeMartino, G. N. and Greene, W. C (1998). Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92, 819-828.[Medline]

Luckey, C. J., King, G. M., Marto, J. A., Venketeswaran, S., Maier, B. F., Crotzer, V. L., Colella, T. A., Shabanowitz, J., Hunt, D. F. and Engelhard, V. H (1998). Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol 161, 112-121.[Abstract/Free Full Text]

Mayrand, S. M. and Green, W. R (1998). Non-traditionally derived CTL epitopes: exceptions that prove the rules?. Immunol.Today 19, 551-556.[Medline]

Momburg, F. and Hammerling, G. J (1998). Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Advan. Immunol 68, 191-256.[Medline]

Monaco, J. J. and Nandi, D (1995). The genetics of proteasomes and antigen processing. Annu. Rev. Genet 29, 729-754.[Medline]

Moore, M. W., Carbone, F. R. and Bevan, M. J (1988). Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777-785.[Medline]

Pamer, E. and Cresswell, P (1998). Mechanisms of MHC class I\320restricted antigen processing. Annu. Rev. Immunol 16, 323-358.[Medline]

Rammensee, H.-G., Friede, T. and Stevanovic, S (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228.[Medline]

Rechsteiner, M., Realini, C. and Ustrell, V (2000). The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem. J 345, 1-15.

Reits, E. A., Vos, J. C., Gromme, M. and Neefjes, J (2000). The major substrates for TAP in vivo are derived from newly synthesized proteins [see comments]. Nature 404, 774-778.[Medline]

Rock, K. L. and Goldberg, A. L (1999). Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev.Immunol 17, 739-779.[Medline]

Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D. and Goldberg, A. L (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771.[Medline]

Romisch, K (1999). Surfing the Sec61 channel: bidirectional protein translocation across the ER membrane. J. Cell Sci 112, 4185-4191.[Abstract]

Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W. and Bennink, J. R (2000). Rapid degradation of a large fraction of newly synthesized proteins by proteasomes [see comments]. Nature 404, 770-774.[Medline]

Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J. and Eisen, H. N (1996). Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4, 565-571.[Medline]

Tanaka, K. and Kasahara, M (1998). The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol. Rev 163, 161-176.[Medline]

Tevethia, S., Tevethia, M., Lewis, A., Reddy, V. and Weissman, S (1983). Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology 128, 319-330.[Medline]

Thrower, J. S., Hoffman, L., Rechsteiner, M. and Pickart, C. M (2000). Recognition of the polyubiquitin proteolytic signal. EMBO J 19, 94-102.[Medline]

Townsend, A. R. M., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D. and McMichael, A. J (1986). The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959-968.[Medline]

Townsend, A. R. M., Bastin, J., Gould, K. and Brownlee, G. G (1986). Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 324, 575-577.[Medline]

Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S. and Smith, G (1988). Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med 168, 1211-1224.[Abstract/Free Full Text]

Turner, G. C. and Varshavsky, A (2000). Detecting and measuring cotranslational protein degradation in vivo. Science 289, 2117-2120.[Abstract/Free Full Text]

Van Pel, A. and Boon, T (1989). T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 29, 75-79.[Medline]

Verma, R. and Deshaies, R. J (2000). A proteasome howdunit: the case of the missing signal. Cell 101, 341-344.[Medline]

Vinitsky, A., Anton, L. C., Snyder, H. L., Orlowski, M., Bennink, J. R. andYewdell, J. W (1997). The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: Involvement of nonproteasomal cyosolic proteases in antigen processing?. J. Immunol 159, 554-564.[Abstract]

Voges, D., Zwickl, P. and Baumeister, W (1999). The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem 68, 1015-1068.[Medline]

Yewdell, J. W., Bennink, J. R. and Hosaka, Y (1988). Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239, 637-640.[Abstract/Free Full Text]

Yewdell, J. W., Anton, L. C. and Bennink, J. R (1996). Defective ribosomal products (DRiPs). A major source of antigenic peptides for MHC class I molecules?. J. Immunol 157, 1823-1826.[Abstract]

Yewdell, J., Anton, L. C., Bacik, I., Schubert, U., Snyder, H. L. and Bennink, J. R (1999). Generating MHC class I ligands from viral gene products. Immunol. Rev 172, 97-108.[Medline]

York, I. A., Goldberg, A. L., Mo, X. Y. and Rock, K. L (1999). Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev 172, 49-66.[Medline]

This article has been cited by other articles:

J. Tellam, C. Smith, M. Rist, N. Webb, L. Cooper, T. Vuocolo, G. Connolly, D. C. Tscharke, M. P. Devoy, and R. Khanna
From the Cover: Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition
PNAS, July 8, 2008; 105(27): 9319 - 9324.
[Abstract] [Full Text] [PDF]

J. Tellam, M. H. Fogg, M. Rist, G. Connolly, D. Tscharke, N. Webb, L. Heslop, F. Wang, and R. Khanna
Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes
J. Exp. Med., March 19, 2007; 204(3): 525 - 532.
[Abstract] [Full Text] [PDF]

A. O. Weinzierl, C. Lemmel, O. Schoor, M. Muller, T. Kruger, D. Wernet, J. Hennenlotter, A. Stenzl, K. Klingel, H.-G. Rammensee, et al.
Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface
Mol. Cell. Proteomics, January 1, 2007; 6(1): 102 - 113.
[Abstract] [Full Text] [PDF]

S.-B. Qian, E. Reits, J. Neefjes, J. M. Deslich, J. R. Bennink, and J. W. Yewdell
Tight Linkage between Translation and MHC Class I Peptide Ligand Generation Implies Specialized Antigen Processing for Defective Ribosomal Products
J. Immunol., July 1, 2006; 177(1): 227 - 233.
[Abstract] [Full Text] [PDF]

E. Milner, E. Barnea, I. Beer, and A. Admon
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
Mol. Cell. Proteomics, February 1, 2006; 5(2): 357 - 365.
[Abstract] [Full Text] [PDF]

S.-B. Qian, M. F. Princiotta, J. R. Bennink, and J. W. Yewdell
Characterization of Rapidly Degraded Polypeptides in Mammalian Cells Reveals a Novel Layer of Nascent Protein Quality Control
J. Biol. Chem., January 6, 2006; 281(1): 392 - 400.
[Abstract] [Full Text] [PDF]

E. Caron, R. Charbonneau, G. Huppe, S. Brochu, and C. Perreault
The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome
Int. Immunol., December 1, 2005; 17(12): 1583 - 1596.
[Abstract] [Full Text] [PDF]

M. Ceppi, M. G. M. de Bruin, T. Seuberlich, C. Balmelli, S. Pascolo, N. Ruggli, D. Wienhold, J. D. Tratschin, K. C. McCullough, and A. Summerfield
Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells
J. Gen. Virol., September 1, 2005; 86(9): 2525 - 2534.
[Abstract] [Full Text] [PDF]

S. Herter, P. Osterloh, N. Hilf, G. Rechtsteiner, J. Hohfeld, H.-G. Rammensee, and H. Schild
Dendritic Cell Aggresome-Like-Induced Structure Formation and Delayed Antigen Presentation Coincide in Influenza Virus-Infected Dendritic Cells
J. Immunol., July 15, 2005; 175(2): 891 - 898.
[Abstract] [Full Text] [PDF]

H. Lelouard, V. Ferrand, D. Marguet, J. Bania, V. Camosseto, A. David, E. Gatti, and P. Pierre
Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins
J. Cell Biol., March 1, 2004; 164(5): 667 - 675.
[Abstract] [Full Text] [PDF]

K. S. Voo, T. Fu, H. Y. Wang, J. Tellam, H. E. Heslop, M. K. Brenner, C. M. Rooney, and R.-F. Wang
Evidence for the Presentation of Major Histocompatibility Complex Class I-restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes
J. Exp. Med., February 17, 2004; 199(4): 459 - 470.
[Abstract] [Full Text] [PDF]

Y. Yin, B. Manoury, and R. Fahraeus
Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1
Science, September 5, 2003; 301(5638): 1371 - 1374.
[Abstract] [Full Text] [PDF]

A. Admon, E. Barnea, and T. Ziv
Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides
Mol. Cell. Proteomics, June 1, 2003; 2(6): 388 - 398.
[Abstract] [Full Text] [PDF]

M. H. Glickman and A. Ciechanover
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Physiol Rev, April 1, 2002; 82(2): 373 - 428.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Yewdell, J. W.

Articles by Bennink, J. R.

Search for Related Content

PubMed

PubMed Citation

Articles by Yewdell, J. W.

Articles by Bennink, J. R.

				J. Tellam, M. H. Fogg, M. Rist, G. Connolly, D. Tscharke, N. Webb, L. Heslop, F. Wang, and R. Khanna Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes J. Exp. Med., March 19, 2007; 204(3): 525 - 532. [Abstract] [Full Text] [PDF]

				A. O. Weinzierl, C. Lemmel, O. Schoor, M. Muller, T. Kruger, D. Wernet, J. Hennenlotter, A. Stenzl, K. Klingel, H.-G. Rammensee, et al. Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface Mol. Cell. Proteomics, January 1, 2007; 6(1): 102 - 113. [Abstract] [Full Text] [PDF]

				S.-B. Qian, E. Reits, J. Neefjes, J. M. Deslich, J. R. Bennink, and J. W. Yewdell Tight Linkage between Translation and MHC Class I Peptide Ligand Generation Implies Specialized Antigen Processing for Defective Ribosomal Products J. Immunol., July 1, 2006; 177(1): 227 - 233. [Abstract] [Full Text] [PDF]

				E. Milner, E. Barnea, I. Beer, and A. Admon The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells Mol. Cell. Proteomics, February 1, 2006; 5(2): 357 - 365. [Abstract] [Full Text] [PDF]

				S.-B. Qian, M. F. Princiotta, J. R. Bennink, and J. W. Yewdell Characterization of Rapidly Degraded Polypeptides in Mammalian Cells Reveals a Novel Layer of Nascent Protein Quality Control J. Biol. Chem., January 6, 2006; 281(1): 392 - 400. [Abstract] [Full Text] [PDF]

				E. Caron, R. Charbonneau, G. Huppe, S. Brochu, and C. Perreault The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome Int. Immunol., December 1, 2005; 17(12): 1583 - 1596. [Abstract] [Full Text] [PDF]

				M. Ceppi, M. G. M. de Bruin, T. Seuberlich, C. Balmelli, S. Pascolo, N. Ruggli, D. Wienhold, J. D. Tratschin, K. C. McCullough, and A. Summerfield Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells J. Gen. Virol., September 1, 2005; 86(9): 2525 - 2534. [Abstract] [Full Text] [PDF]

				S. Herter, P. Osterloh, N. Hilf, G. Rechtsteiner, J. Hohfeld, H.-G. Rammensee, and H. Schild Dendritic Cell Aggresome-Like-Induced Structure Formation and Delayed Antigen Presentation Coincide in Influenza Virus-Infected Dendritic Cells J. Immunol., July 15, 2005; 175(2): 891 - 898. [Abstract] [Full Text] [PDF]

				H. Lelouard, V. Ferrand, D. Marguet, J. Bania, V. Camosseto, A. David, E. Gatti, and P. Pierre Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins J. Cell Biol., March 1, 2004; 164(5): 667 - 675. [Abstract] [Full Text] [PDF]

				K. S. Voo, T. Fu, H. Y. Wang, J. Tellam, H. E. Heslop, M. K. Brenner, C. M. Rooney, and R.-F. Wang Evidence for the Presentation of Major Histocompatibility Complex Class I-restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes J. Exp. Med., February 17, 2004; 199(4): 459 - 470. [Abstract] [Full Text] [PDF]

				Y. Yin, B. Manoury, and R. Fahraeus Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1 Science, September 5, 2003; 301(5638): 1371 - 1374. [Abstract] [Full Text] [PDF]

				A. Admon, E. Barnea, and T. Ziv Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides Mol. Cell. Proteomics, June 1, 2003; 2(6): 388 - 398. [Abstract] [Full Text] [PDF]

				M. H. Glickman and A. Ciechanover The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction Physiol Rev, April 1, 2002; 82(2): 373 - 428. [Abstract] [Full Text] [PDF]